Home/ Stocks/ SLS

SELLAS Life Sciences Group, Inc. Common Stock

SLS XNAS

$8.42 +0.45 (+5.71%) ▲ 15-min delayed

Open

$8.03

High

$8.42

Low

$7.14

Volume

7.62M

Market Cap

$1.70B

About SELLAS Life Sciences Group, Inc. Common Stock

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 13 Website →

Related Market News

No specific coverage for SLS yet. Check out our latest market news or earnings calendar.

Get SLS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on SELLAS Life Sciences Group, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.